Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$1.18 - $2.18 $14,544 - $26,870
-12,326 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$1.48 - $2.35 $18,242 - $28,966
12,326 New
12,326 $28,000
Q2 2021

Aug 12, 2021

SELL
$1.87 - $2.7 $42,104 - $60,793
-22,516 Closed
0 $0
Q4 2020

Feb 25, 2021

BUY
$1.99 - $3.25 $44,806 - $73,177
22,516 New
22,516 $45,000

About Cidara Therapeutics, Inc.


  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.63B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.